Loading organizations...
§ Private Profile · Seattle, WA, USA
Biotech company developing non-viral gene delivery for muscle cells.
Myosana Therapeutics has raised $6.0M across 2 funding rounds.
Myosana Therapeutics has raised $6.0M in total across 2 funding rounds.
Myosana Therapeutics has raised $6.0M across 2 funding rounds. Most recently, it raised $5.0M Seed in January 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 25, 2023 | $5M Seed | John Ballantyne | Cureduchenne Ventures, Sharon Hesterlee, Parent Project Muscular Dystrophy | Announced |
| Apr 22, 2020 | $1M Seed | Debra Miller | — | Announced |
Myosana Therapeutics has raised $6.0M in total across 2 funding rounds.
Myosana Therapeutics's investors include John Ballantyne, CureDuchenne Ventures, Sharon Hesterlee, Parent Project Muscular Dystrophy, Debra Miller.